Related Experiment Videos
[Experience with second-look curettage]
Zentralblatt Fur Gynakologie
|January 1, 1978
Summary
Second-look curettage after endometrial cancer radiotherapy can detect residual cancer in 5 of 31 patients. This procedure helps assess treatment effectiveness and guides further management for uterine cancer survivors.
Area of Science:
- Gynecologic Oncology
- Radiation Oncology
- Pathology
Context:
- Endometrial cancer treatment often involves radiotherapy.
- Assessing treatment response and detecting recurrence is crucial for patient outcomes.
- Second-look curettage is a potential tool for post-treatment surveillance.
Purpose:
- To evaluate the utility of second-look curettage in patients treated for endometrial cancer.
- To determine the rate of residual or recurrent endometrial carcinoma after radiotherapy.
- To discuss the indications and feasibility of this surveillance method.
Summary:
- A study involving 31 patients undergoing second-look curettage 3-12 months post-radiotherapy for endometrial cancer.
- Microscopic examination revealed persistent endometrial carcinoma in 5 cases and atypical tissue in 1 case.
- Curettage was not feasible in 2 patients, and the indications for the procedure were analyzed.
Impact:
- Findings highlight the role of second-look curettage in identifying residual endometrial cancer post-radiotherapy.
- This can inform clinical decision-making regarding further treatment or surveillance strategies.
- The study contributes to understanding the effectiveness of post-treatment monitoring in endometrial cancer.